Literature DB >> 33638350

Hippocampal Sclerosis in Frontotemporal Dementia: When Vascular Pathology Meets Neurodegeneration.

Anne Sieben1,2,3,4, Tim Van Langenhove2,3, Yannick Vermeiren1,5, Helena Gossye3,6,7,8, Marleen Praet9, Dimitri Vanhauwaert10, Céline Cousaert11, Sebastiaan Engelborghs1,8, Robrecht Raedt2, Paul Boon2, Patrick Santens2, Peter Paul De Deyn1,3,12, Ken R Bracke13, Katia De Meulemeester4, Christine Van Broeckhoven3,14,15, Jean-Jacques Martin1, Maria Bjerke1,16.   

Abstract

Hippocampal sclerosis (HS) is a common neuropathological finding and has been associated with advanced age, TDP-43 proteinopathy, and cerebrovascular pathology. We analyzed neuropathological data of an autopsy cohort of early-onset frontotemporal dementia patients. The study aimed to determine whether in this cohort HS was related to TDP-43 proteinopathy and whether additional factors could be identified. We examined the relationship between HS, proteinopathies in frontotemporal cortices and hippocampus, Alzheimer disease, cerebrovascular changes, and age. We confirmed a strong association between HS and hippocampal TDP-43, whereas there was a weaker association between HS and frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP). Nearly all of the FTLD-TDP cases had TDP-43 pathology in the hippocampus. HS was present in all FTLD-TDP type D cases, in 50% of the FTLD-TDP A cohort and in 6% of the FTLD-TDP B cohort. Our data also showed a significant association between HS and vascular changes. We reviewed the literature on HS and discuss possible pathophysiological mechanisms between TDP-43 pathology, cerebrovascular disease, and HS. Additionally, we introduced a quantitative neuronal cell count in CA1 to objectify the semiquantitative visual appreciation of HS.
© 2021 American Association of Neuropathologists, Inc. All rights reserved.

Entities:  

Keywords:  Cerebrovascular disease; FTLD-TDP; Frontotemporal dementia; Frontotemporal lobar degeneration; Hippocampal sclerosis; TDP-43

Mesh:

Substances:

Year:  2021        PMID: 33638350     DOI: 10.1093/jnen/nlab010

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  1 in total

1.  Differences in Symptomatic Presentation and Cognitive Performance Among Participants With LATE-NC Compared to FTLD-TDP.

Authors:  Merilee A Teylan; Charles Mock; Kathryn Gauthreaux; Jessica E Culhane; Gregory Jicha; Yen-Chi Chen; Kwun C G Chan; Walter A Kukull; Peter T Nelson; Yuriko Katsumata
Journal:  J Neuropathol Exp Neurol       Date:  2021-10-01       Impact factor: 3.685

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.